![Garry Michael Kann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Garry Michael Kann
Corporate Officer/Principal at
ENDONOVO THERAPEUTICS, INC.
Profile
Garry Michael Kann is currently the Head of Corporate Development at Endonovo Therapeutics, Inc. and a Partner at The Firebird Partnership Ltd. He obtained an undergraduate degree from Kean University.
Garry Michael Kann active positions
| Companies | Position | Start |
|---|---|---|
| ENDONOVO THERAPEUTICS, INC. | Corporate Officer/Principal | 2022-02-28 |
The Firebird Partnership Ltd.
 The Firebird Partnership Ltd. Financial ConglomeratesFinance Provides investment services | Corporate Officer/Principal | - |
Training of Garry Michael Kann
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
2
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Endonovo Therapeutics, Inc.
 Endonovo Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops off the shelf regenerative products that no longer require the injection of stem cells | Health Technology |
Kean University
 Kean University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Firebird Partnership Ltd.
The Firebird Partnership Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
- Stock Market
- Insiders
- Garry Michael Kann
